Lexaria Bioscience Corp. — Director's Dealing 2014

Mar 27, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, President, CEO and Chairman, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-21	Common Shares	P	100067	$0.12	Acquired	4808214	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-21	Warrants	$0.25	P	100067	Acquired	2015-09-21	Common Shares (100067)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	1488561	Direct
Common Shares	3219586	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.2	2015-01-20	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	200000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	225000	Direct